EUVIMEDEUVIMED entdecken
Open Access

Associations of AMH in Midreproductive Years with Bone Mineral Density and Turnover Markers in Midlife

Siwen Wang iD, Elaine W Yu iD, Marie-France Hivert iD, Sheryl L Rifas-Shiman iD, Jan L Shifren iD, Maryam Kazemi, Emily Oken iD, Jorge E Chavarro iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Siwen Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Bone Density, Anti-Mullerian Hormone, Biomarkers, Bone Remodeling. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH Research, The National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The concentration of circulating anti-Müllerian hormone (AMH) predicts short-term (3-5 years) bone loss around menopause. Whether AMH during midreproductive years predicts bone health over a decade later is unknown.

Objective

To study the association of AMH levels in midreproductive years with bone density and turnover biomarkers measured after ∼14 years of follow-up.

Methods

We assessed plasma AMH in 2003-2006 (mean 37.0 years, SD 5.1) among 450 parous women (71% White) in a US longitudinal cohort, and bone mineral density (BMD; spine, hip, and femoral neck, measured by dual-energy X-ray absorptiometry) in 2017-2021 (mean 51.0 years, SD 5.1). Secondary outcomes were plasma levels of procollagen type I N-propeptide (PINP) and type I collagen cross-linked C telopeptide (CTX-I).

Results

In linear regression models adjusted for demographics and lifestyle, compared with women with AMH >3.5 ng/mL, those with AMH <1.0 ng/mL had lower BMD (g/cm2) at follow-up (beta [95% CI] spine: −.06 [−0.10, −0.02]; hip: −.05 [−0.08, −0.02]; femoral neck: −.03 [−0.06, 0.00]) and higher bone turnover markers (beta [95% CI] PINP: .36 SD [0.10, 0.63]; CTX-I: .34 SD [0.07, 0.60]). The association of AMH with spine BMD was more pronounced among postmenopausal women in contrast to associations with bone turnover markers, which were more pronounced among women who had not yet reached menopause. The associations between AMH and BMD were primarily mediated by menopausal status at follow-up.

Conclusion

Lower AMH during midreproductive years is associated with lower BMD and higher bone turnover 14 years later. Ovarian reserve during midreproductive years may be a valuable predictor of long-term bone health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone DensityAnti-Mullerian HormoneBiomarkersBone RemodelingMenopauseOsteoporosis, PostmenopausalHumansFemaleMiddle AgedLongitudinal StudiesCollagen Type IAbsorptiometry, PhotonProcollagenAdultFollow-Up StudiesPeptidesPeptide Fragments

Stichwörter der Autor:innen

anti-Müllerian hormonebone mineral densitybone turnover markersmenopauseovarian functionovarian reserve

Substanzen

Anti-Mullerian HormoneBiomarkersCollagen Type IProcollagencollagen type I trimeric cross-linked peptidePeptidesPeptide Fragmentsprocollagen Type I N-terminal peptide

Autor:innen und Institutionen

  • Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
  • Endocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Division of Chronic Disease Research across the Lifecourse (CoRAL), Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA.
  • Diabetes Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

ORCID-Profile: Siwen Wang, Elaine W Yu, Marie-France Hivert, Sheryl L Rifas-Shiman, Jan L Shifren, Emily Oken, Jorge E Chavarro

Förderung

  • NIA NIH HHS
  • NIH Research
  • The National Institute on Aging
  • Office of Research on Women's Health
  • Irene M. & Fredrick J. Stare Nutrition Education Fund Doctoral Scholarship and Mayer Fund Doctoral Scholarship
  • Office of Research on Women’s Health

Zitieren

APA

Wang, S., Yu, E. W., Hivert, M. F., Rifas-Shiman, S. L., Shifren, J. L., Kazemi, M., Oken, E., & Chavarro, J. E. (2025). Associations of AMH in Midreproductive Years with Bone Mineral Density and Turnover Markers in Midlife. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae694

Vancouver

Wang S, Yu EW, Hivert MF, Rifas-Shiman SL, Shifren JL, Kazemi M, et al. Associations of AMH in Midreproductive Years with Bone Mineral Density and Turnover Markers in Midlife. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae694

BibTeX
@article{Wang2025,
  author = {Wang, Siwen and Yu, Elaine W and Hivert, Marie-France and Rifas-Shiman, Sheryl L and Shifren, Jan L and Kazemi, Maryam and Oken, Emily and Chavarro, Jorge E},
  title = {Associations of AMH in Midreproductive Years with Bone Mineral Density and Turnover Markers in Midlife},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae694}
}
Kostenlos starten →